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ABSTRACT
Introduction: It is hypothesized that health 
and patient-reported outcomes in asthma are 
positively influenced by the level of patient 
satisfaction with their inhaler device. This paper 
uses data from a real-world observational study 
to investigate the extent of the relationship 
between inhaler satisfaction and patient 
compliance, and the influence this has on health 
and patient-reported outcomes. Methods: Data 
were drawn from the Adelphi Respiratory Disease 
Specific Programme® (Adelphi, Macclesfield, UK), 
a cross-sectional study of consulting patients in 
five European countries undertaken between 
June and September 2009. A range of clinical 
and patient-reported outcomes were observed 
allowing analysis of these and their relationship 
with patient-reported inhaler satisfaction and 
patient compliance. Results: The analysis 
demonstrates that for the majority of patients 
the higher the level of satisfaction that the 
patient reports for their device the more likely 
the patient is observed to be compliant and to 
experience better outcomes including quality of 
life (as measured by EuroQol 5 Dimensions [EQ-
5D] utility score, P<0.001), fewer exacerbations 
(P<0.001), fewer hospital visits (P=0.011), fewer 
healthcare visits (P=0.001), fewer primary care 
physician visits (P=0.001), and fewer sleep 
disturbances (P<0.001). Conclusion: The level 
of patient satisfaction with their inhaler device 
is observed to have a positive influence on 
the treatment goals for asthma through its 
association with improved compliance.
Keywords: asthma; compliance; device; health 
outcomes; inhaler; patient-reported outcomes
INTRODUCTION
Asthma is a common inflammatory condition 
of the upper respiratory tract estimated to affect 
approximately 300 million people worldwide1
and with prevalence increasing globally by 50% 
every decade.2
Recent studies in Europe,3 the United 
States,4 Japan,5 and the Asia-Pacific region6
indicate that asthma is underdiagnosed and 
undertreated and that there is considerable 
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room for improvement in the management of 
the condition.
Asthma is commonly treated with 
bronchodilator and anti-inflammatory drugs, 
in the majority of cases delivered by inhaler 
as advocated by current treatment guidelines.7
Today there exists a wide choice of inhalers 
and improvements are constantly being 
developed to optimize drug delivery and ease 
of use. Improvement in the management of the 
condition is therefore reliant not only on the 
medications themselves but also on their effective 
delivery.8 Poor inhaler technique is common 
and associated with noncompliance.9 The 
investigators selected the degree of satisfaction 
with the inhaler as a reliable indication of a 
patient’s ability to successfully use their inhaler 
and thus potentially improve their compliance. 
In this context, satisfaction is defined as the 
extent to which the inhaler fulfills the desires, 
expectations, and requirements of the patient in 
terms of the patient’s expectation of the features 
of the inhaler. The investigators went on to 
study the association between satisfaction with 
the inhaler device and compliance.
This paper focuses on the behavioral 
and attitudinal evidence collected by one 
observational and health outcomes research-based 
organization under the label of Disease Specific 
Programmes (DSPs®; Adelphi, Macclesfield, UK). 
The DSPs are large, multinational, observational 
studies of clinical practice, designed to capture 
a cross-section of real-world data. These are an 
established method for investigating current 
treatment practices across a wide range of disease 
areas.10 The Respiratory DSP accurately reflects 
the current symptom prevalence and severity 
among the consulting population and associated 
treatment practices of respiratory conditions 
including asthma.11
The present work investigates the extent of 
the relationship between inhaler satisfaction 
and patient compliance and the influence this 
has on health and patient-reported outcomes.
METHODS
Study Design
The Respiratory DSP was conducted between 
June and September 2009, including specialists 
and primary care physicians and their patients 
in France, Germany, Italy, Spain, and the UK. 
Physicians completed a patient record form 
(PRF) for six consecutive consulting adult 
asthma patients, and the same patients were 
invited to fill out a self-completion form (PSC). 
The full methodology for this survey has been 
outlined previously.12
Physicians were identified by the local 
DSP fieldwork teams from public lists of 
healthcare professionals according to predefined 
selection criteria to ensure that the sample was 
representative of asthma management in each 
participating country. Physicians were checked 
for their eligibility to participate in the DSP in 
terms of specialty, whether they are personally 
responsible for treatment decisions, and how 
many patients they see in a typical week (in total 
and with asthma in order to avoid physicians with 
an abnormal workload). Candidate respondents 
who met the predefined eligibility criteria were 
subsequently invited to participate in the study. 
To avoid potential selection bias due to variable 
population densities in different geographical 
regions in a given country, an appropriately 
larger sample of physicians was identified in 
densely populated areas than in more sparsely 
populated areas. As the methodology requires 
the next six presenting asthma patients for each 
physician, the DSP sample is representative 
of the consulting population. Patients were 
invited by the physician to complete the PSC 
independently and return it in a sealed envelope. 
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At no stage does the physician see or influence 
the responses made by the patient.
All responses were voluntary and anonymous 
to preserve patient confidentiality and to avoid 
bias at the data collection and analysis phases. 
The study adheres to version 6.3 of the European 
Pharmaceutical Market Research Association 
(EphMRA) code of conduct governing market 
research,13 including written informed consent 
of all patients for anonymous and aggregated 
reporting of research findings based on the 
questionnaires employed. Matching the 
physician and patient responses via patient/
physician study numbers allows the PSC data to 
be linked with comparable data recorded on the 
physician-completed PRF to highlight any areas 
of disparity and/or agreement.
Patient Inhaler Satisfaction
Patients were asked to rate their satisfaction 
across 13 attributes specific to their asthma 
inhaler device on a seven-point Likert scale, as 
well as their overall satisfaction with the device. 
The list of attributes (see Table 1) was created by 
Adelphi for the Respiratory DSP in consultation 
with physicians.
Compliance
The cross-sectional nature of the DSP 
methodology does not permit the observation 
of actual compliance. For the purposes of 
this paper, therefore, the term compliance is 
defined as the extent to which the patients are 
perceived to follow their physician’s prescribing 
instructions and advice. Physicians were asked 
to rate separately patients’ compliance with 
regards to frequency of administrations per day 
and inhaler device usage. Both were measured 
using five-point Likert scales, where 1=not at all 
compliant and 5=fully compliant.
Use of a Likert scale can be considered a 
suitable point in time method of measuring 
compliance in that it demonstrates enough 
sensitivity to differentiate any patient’s 
compliance relative to others.14
Health and Patient-Reported Outcomes
The following health and patient-reported 
outcomes were analyzed against  the 
compliance rating provided by physicians: 
quality of life (as measured by the EuroQol 5 
D imens ions  [EQ-5D]  u t i l i t y  s co re ) , 
exacerbations, hospital visits, healthcare 
visits, and sleep disturbances (as measured 
Table 1. List of 13 attributes associated with inhaler usage.
No. Attribute
1. It is built to last and will not break easily
2. It is easy to hold and carry
3. The instructions are simple and easy to follow
4. No need for me to put the drug into the inhaler 
before I use it
5. I do not need to breathe in at the same time as I press 
my inhaler
6. I do not need to breathe in hard to inhale my 
medication 
7. I get the same amount of medication delivered to my 
lungs each time
8. It tells me when my dose of medication has been 
inhaled correctly
9. It tells me how many doses of my medicine I have left
10. It does not need to be cleaned
11. The inhaler locks when it is empty so I cannot use it 
anymore
12. I can throw the inhaler away and get a new one with 
each prescription
13. I keep the inhaler and refill it myself with each 
prescription.
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by the Jenkins Sleep Scale15). The EQ-5D and 
Jenkins Sleep Scale are recognized instruments 
for measuring patient reported outcomes. For 
exacerbations, hospital visits, and healthcare 
visits, we used standard questions taken from 
the DSP methodology.
Statistical Methods
Ordinary least squares regression was used 
to relate compliance to overall satisfaction 
with inhaler, severity, gender, age, ethnicity, 
and number of maintenance drugs (log 
transformed). A generalized additive model16
was used to investigate further the relationship 
for compliance to overall satisfaction with 
inhaler, without making any assumptions 
for the shape of the association. Sequential 
regression with average over orderings and 
bootstrap confidence intervals17 was used 
to investigate the relationship with overall 
satisfaction and inhaler characteristics. This 
method is appropriate where the independent 
variables are highly correlated with each other.17
The associations of the health outcome data 
with compliance with inhaler were modeled 
using generalized additive models, which 
again made no assumption about the shape of 
the relationship.
RESULTS
A total of 582 physicians participated in the study 
(see Table 2) providing a total of 2135 patient 
records (see Table 3).
A total of 1400 patients provided PSCs 
and these were matched to the corresponding 
physician-completed PRFs. Of these 1400 patients, 
1345 answered the inhaler attribute satisfaction 
section of the PSC (France 311; Germany 328; 
Italy 316; Spain 295; UK 95).
In order to generate one compliance rating 
score for each patient, the two Likert scales 
measuring frequency and inhaler usage were 
tested for their degree of correlation and showed 
a Cronbach’s alpha of 0.924. Since the widely 
accepted social science cut-off level is that alpha 
should be 0.7 or higher for a set of items to 
be considered a scale,18 the overall mean score 
was taken as the compliance rating for each 
patient (see Figure 1). Therefore for the majority 
of patients, the physician gave the patient the 
same score so the mean score is a whole number 
between 1 and 5. For those patients whose 
physician gave them a different score on the two 
scales, their overall rating is the mean of the two 
scores, for example 4 and 5=4.5.
In the case of physician-perceived reporting 
used for this study, 63% of physicians gave a 
Table 2. Study physicians: distribution and specialty.
Physicians France Germany Italy Spain UK Total
Primary care physicians 50 50 50 50 52 252
Pulmonologists 50 50 50 50 50 250
Allergologists 20 20 20 20 - 80
Total 120 120 120 120 102 582
Table 3. Study patients: distribution by country and specialty of physician who completed the patient record.
Physicians France Germany Italy Spain UK Total
Primary care physicians 196 264 220 195 111 986
Specialists 217 384 294 210 44 1149
Total 413 648 514 405 155 2135
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different compliance rating for at least two of 
their six patient records provided. This provides 
evidence that physicians were rating patient 
compliance relative to their other patients.
Figure 1 shows that the mean physician-
perceived compliance rating follows a highly 
skewed distribution with 49% of patients 
(n=1051) given the fully compliant rating of 5 on 
both scales and the remaining 51% of patients 
(n=1084) considered less than fully compliant to 
a greater or lesser degree.
Figure 2 shows the highest mean scores 
for patient-reported satisfaction with their 
inhaler related to those attributes which reflect 
convenience, durability, and simplicity: easy to 
hold and carry, no need to put the drug into 
the inhaler before use, built to last/will not 
break easily, and simple and easy to follow 
instructions. Sequential regression with average 
over orderings and bootstrap 95% confidence 
intervals was used to present the list of inhaler 
attributes according to which is most predictive 
of overall inhaler satisfaction (or dissatisfaction). 
As can be seen in Figure 3, the top five drivers 
of inhaler satisfaction were: built to last/will not 
break easily, easy to hold and carry, instructions 
are simple and easy to follow, I get the same 
amount of medication delivered to my lungs 
each time, and no need to put the drug into the 
inhaler before use.
Four of these attributes (1, 2, 3, and 5) are 
related to convenience for the patient and 
together these account for 68% of the explained 
variation contributing to overall satisfaction.
Figure 4 shows the degree of the relationship 
between patient-reported overall satisfaction 
with their inhaler device and compliance 
while considering the influence of a number of 
confounding variables: age, gender, ethnicity, 
number of maintenance drugs, and physician-
perceived severity.
There was a significant relationship 
(P<0.001) between the level of compliance 
and patient-reported satisfaction with their 
inhaler device. For the total patient sample, 
the confounding measures were all found to be 
insignificant and therefore have no relationship 
with compliance.
Figure 5 shows that a higher degree of 
inhaler satisfaction is associated with a 
significantly better level of physician-perceived 
compliance (P<0.001).
Observation of the Relationships between 
Device Satisfaction, Compliance, and Health 
and Patient-Reported Outcomes
In this study, the majority of patients (92%) 
support the hypothesis that health and patient-
reported outcomes in asthma are positively 
influenced by the level of patient satisfaction 
with their inhaler device. For these patients, 
improved quality of life, reduced number of 
exacerbations, reduced visits to primary care 
practitioner and other healthcare professionals 
(asthma nurses, for example), and reduction in 
sleep disturbance were shown to be associated 
with the level of satisfaction with their device 
and consequently physician-reported level of 
compliance. For 100% of patients, a reduction 
Figure 1. Distribution of physician-perceived patient 
compliance (mean of two 1-5 scales). Base: all adult asthma 
patients. *A compliance rating of 5 on one scale and 4 
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Figure 3. Influence of patient-reported satisfaction with specific inhaler attributes on overall satisfaction. *Percentage of R2 
(total R2=0.613).
Figure 2. Patient satisfaction with specific inhaler attributes. Error bars show bootstrap 95% confidence intervals.
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in the number of hospital visits was associated 
with the level of satisfaction with their device 
and associated physician-reported level 
of compliance.
Figures 6 to 11 illustrate the relationship 
between physician-perceived compliance and 
EQ-5D utility score, number of exacerbations in 
the last 12 months, hospitalizations as a result 
of an exacerbation, primary care physician 
visits, combined healthcare professional visits, 
and sleep disturbance. In each instance it was 
observed that a higher physician-perceived 
compliance rating was significantly associated 
Figure 4. Degree of association of compliance with overall 
inhaler satisfaction and selected patient characteristics.
Figure 5. Relationship of compliance rating and overall 
inhaler satisfaction. R2=0.060. P<0.001.
Figure 6. Higher physician-perceived compliance rating 
is associated with a better EuroQol 5 Dimensions 
(EQ-5D) utility score (P<0.001). Shading represents 
95% confidence interval. Base: all adult asthma patients. 
QoL=quality of life.
Figure 7. Higher physician-perceived compliance 
rating is associated with experiencing a lower number of 
exacerbations in the last 12 months as reported by their 
physician (P<0.001). Shading represents 95% confidence 
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Figure 8. Higher physician-perceived compliance rating 
is associated with fewer attacks severe enough to require a 
visit to their primary care physician in the last 12 months as 
reported by the patient (P=0.001). Shading represents 95% 
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Figure 9. Higher physician-perceived compliance rating 
is associated with making fewer visits to a healthcare 
professional in the last 12 months as reported by the 
patient (P=0.001). Shading represents 95% confidence 
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Figure 10. Higher physician-perceived compliance rating is 
associated with a lower number of hospital visits as a result 
of an exacerbation in the last 12 months as reported by the 
physician (P=0.011). Shading represents 95% confidence 




































Figure 11. Higher physician-perceived compliance rating 
is associated with reporting fewer sleep disturbances 
(P<0.001). Shading represents 95% confidence interval. 
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with a better outcome for the patient in terms 
of a higher utility score and fewer exacerbations, 
hospitalizations, healthcare professional visits, 
and sleep disturbances. This was shown to be 
consistent for the same 92% of the sample for 
all outcome variables with the exception of 
hospitalizations due to an exacerbation when it 
was applicable for all patients. For 8% of patients 
this association was not observed.
DISCUSSION
There is a clear need for accurate understanding 
of asthma management and the impact that real-
world clinical practice by physicians has on the 
improved health and patient-reported outcomes 
of asthma patients. Behavioral and attitudinal 
evidence is one data source that can inform our 
understanding of asthma management.10
In asthma management, the inhaler device 
has an important and predominant place in 
the treatment armamentarium. The Adelphi 
Respiratory DSP collects behavioral and 
attitudinal evidence from asthma patients about 
their preferences and perceptions for the inhaler 
they are using. The DSP also collects data on the 
physician-perceived compliance of the same 
patient. Our results on the level of compliance 
and patient-reported satisfaction with their 
inhaler device complement previous research 
suggesting that adherence cannot be explained 
by certain patient characteristics such as patient 
age and gender or race.8
We collected objective observational data 
from both patients and physicians that allowed 
us to assess health and reported outcomes. In 
this study we developed a technique to allow 
us to study the relationship between these 
three areas, as it was felt that the behavior 
and attitude of patients towards their inhaler 
device may influence their health and patient-
reported outcomes.
Real-world data are valuable tools to develop 
our understanding of the behavior and attitude 
of patients in the context of their treatment. This 
understanding can assist us in designing improved 
treatment management strategies, which in turn 
may improve the outcome of the asthma patient; 
a widely accepted unmet need.3-6 We accept that 
there are inevitable limitations when collecting 
real-world data, specifically the selection and 
diagnosis of patients, as in the absence of formal 
randomization this is contingent on the integrity 
of the participating physicians rather than 
formal source verification procedures. Moreover, 
diagnosis and assessment of outcome is based 
on the judgment and diagnostic skills of the 
respondent physician.10 Although the DSP can be 
used to identify association, a further limitation 
is that being cross-sectional it cannot be used to 
demonstrate cause and effect. Additionally, the 
association between satisfaction and health and 
patient-reported outcomes may be explained by 
other factors not explored in this study such as 
the relationship between patient and physician 
and the disposition of the individual patient. 
Despite these limitations, the results provide 
helpful and objective evidence of the importance 
in terms of health and patient-reported outcomes 
of patient satisfaction with their device.
The physician’s perception or reporting of 
compliance in this study was captured via a 
Likert scale, and represents one of a number of 
approaches that can be employed to measure the 
degree of patient compliance. Other approaches 
include self-reporting, pill counts, inhaler 
weighing, pharmacy records, and drug level 
monitoring. These have been evaluated in detail 
elsewhere and each has been shown to have its 
own strengths and weaknesses.19,20
In the majority of patients (92%), this study 
observed an association on a number of health 
and patient-reported outcomes with the level 
of satisfaction with device and with physician-
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reported compliance. Further analysis of the small 
proportion (8%) of patients who did not show 
this association, indicates that these patients are 
classified by their physician as being very mild 
and are perceived by the physician as being 
noncompliant. For these patients the analysis 
shows that poor compliance is associated with 
better outcomes. This observation is consistent 
with observations made previously whereby 
adherence, and by implication compliance, 
is influenced by the patients’ perception 
of their disease, and a lack of symptoms is 
interpreted by patients as a disease that can be 
treated episodically.20
The importance of patient involvement 
in their disease and the desirability of a 
partnership between patient and physician is 
widely accepted.12 Our findings suggest that, 
for the majority of asthma patients, satisfaction 
with their device directly associates with their 
compliance and this correlates with improved 
outcome on a number of relevant clinical and 
patient-reported measures. Therefore increased 
patient involvement in the choice of device, 
and thus development of concordance as well 
as wider recognition of the important features 
that device manufacturers should consider when 
developing or enhancing inhaler devices, might 
be expected to result in an improved outcome 
for the asthma patient.
In our study we measured physician-reported 
perception of compliance. We believe a future 
study should investigate the relationship between 
treatment adherence and device satisfaction, 
and should collect treatment adherence data 
from the patient using a robust instrument 
such as the Beliefs in Medicine Questionnaire.8 
We believe that randomized controlled studies 
assessing the potential of new devices to 
improve asthma treatment should also measure 
satisfaction with device, alongside measurement 
of lung deposition.
CONCLUSION
Overall patient satisfaction with their inhaler 
device is an important factor in encouraging 
patient compliance. If physicians made 
particular effort to select an inhaler that satisfies 
the patient, including attention to features 
associated with convenience, patient compliance 
with their asthma treatment would be expected 
to improve. This study further demonstrates the 
relationship of good compliance with better 
outcomes of the patient and points to a need for 
physicians to understand the central role that 
patient satisfaction with inhaler device plays in 
achieving better patient compliance.
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